Journal of Clinical Endocrinology & Metabolism, Vol 81, 1927-1932, Copyright © 1996 by Endocrine Society

ARTICLES

Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations compared to stimulated and night growth hormone in the evaluation of short children--a clinical research center study

SB Nunez, G Municchi, KM Barnes and SR Rose
Developmental Endocrinology Branch, National Institutes of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA.

To evaluate the relative usefulness of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 (IGFBP-3) in screening for GH status, GH stimulation (arginine-insulin/L-DOPA) tests and overnight GH studies (every 20 min sampling) were performed in 104 healthy short children (32 girls), aged 3-16 yr (height, -1.8 or more SD). IGFBP-3 had no advantage over IGF-I in screening sensitivity or specificity. IGF-I correlated with mean nighttime GH. Both IGF-I and IGFBP-3 correlated with peak stimulated GH. To identify more than 90% of children with GH deficiency (GHD) and borderline GHD, the mean values for age for IGF-I and IGFBP-3 were required as the cut-off criterion. However, at this criterion, 70% or more of idiopathic short stature (ISS) children would have to undergo testing to identify 90% of GHD or borderline GHD. More stringent criteria (-1.0, -1.64, and -2.0 SD) were more specific, but lost sensitivity. A practical application is suggested. Screening use of IGF-I with criterion of -1.0 SD would identify a subgroup that includes 88% of GHD, 71% of borderline GHD, and 46% of ISS. Both IGF-I and IGF-BP-3 higher than -1.0 SD would accurately identify 68% of ISS as not needing GH testing. Evaluation of growth velocity would identify the remaining children requiring definitive testing. Thus, combined screening for GHD using both IGF-I and IGFBP-3 has no better sensitivity than either test alone. However, such combined screening will improve the specificity and thus decrease the number of normal but short children who might otherwise undergo unnecessary testing.

This article has been cited by other articles:

				J. C. Lui, G. P. Finkielstain, K. M. Barnes, and J. Baron An imprinted gene network that controls mammalian somatic growth is down-regulated during postnatal growth deceleration in multiple organs Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R189 - R196. [Abstract] [Full Text] [PDF]

				B. P Hauffa, N. Lehmann, M. Bettendorf, O. Mehls, H.-G. Dorr, N. Stahnke, H. Steinkamp, E. Said, M. B Ranke, and participating members of the German KIGS Board/Med Central laboratory reassessment of IGF-I, IGF-binding protein-3, and GH serum concentrations measured at local treatment centers in growth-impaired children: implications for the agreement between outpatient screening and the results of somatotropic axis functional testing Eur. J. Endocrinol., November 1, 2007; 157(5): 597 - 603. [Abstract] [Full Text] [PDF]

				S. Cianfarani, A. Liguori, S. Boemi, M. Maghnie, L. Iughetti, M. Wasniewska, M. E. Street, S. Zucchini, G. Aimaretti, and D. Germani Inaccuracy of Insulin-Like Growth Factor (IGF) Binding Protein (IGFBP)-3 Assessment in the Diagnosis of Growth Hormone (GH) Deficiency from Childhood to Young Adulthood: Association to Low GH Dependency of IGF-II and Presence of Circulating IGFBP-3 18-Kilodalton Fragment J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6028 - 6034. [Abstract] [Full Text] [PDF]

				H. R. Boquete, P. G. V. Sobrado, H. L. Fideleff, A. M. Sequera, A. V. Giaccio, M. G. Suarez, G. F. Ruibal, and M. Miras Evaluation of Diagnostic Accuracy of Insulin-Like Growth Factor (IGF)-I and IGF-Binding Protein-3 in Growth Hormone-Deficient Children and Adults Using ROC Plot Analysis J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4702 - 4708. [Abstract] [Full Text] [PDF]

				A. S. MartÍnez, H. M. Domené, M. G. Ropelato, H. G. Jasper, P. A. Pennisi, M. E. Escobar, and J. J. Heinrich Estrogen Priming Effect on Growth Hormone (GH) Provocative Test: A Useful Tool for the Diagnosis of GH Deficiency J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4168 - 4172. [Abstract] [Full Text]

				H. Guyda Four Decades of Growth Hormone Therapy for Short Children: What Have We Achieved? J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4307 - 4316. [Full Text]

				H. Olivecrona, A. Hilding, C. Ekström, H. Barle, B. Nyberg, C. Möller, P. J. Delhanty, R. C. Baxter, B. Angelin, T. J. Ekström, et al. Acute and Short-Term Effects of Growth Hormone on Insulin-Like Growth Factors and Their Binding Proteins: Serum Levels and Hepatic Messenger Ribonucleic Acid Responses in Humans J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 553 - 560. [Abstract] [Full Text]

				N. Kawai, S. Kanzaki, S. Takano-Watou, C. Tada, Y. Yamanaka, T. Miyata, M. Oka, and Y. Seino Serum Free Insulin-Like Growth Factor I (IGF-I), Total IGF-I, and IGF-Binding Protein-3 Concentrations in Normal Children and Children with Growth Hormone Deficiency J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 82 - 89. [Abstract] [Full Text]

				R. L. Hintz The Role of Auxologic and Growth Factor Measurements in the Diagnosis of Growth Hormone Deficiency Pediatrics, August 1, 1998; 102(2): 524 - 526. [Abstract] [Full Text]

				S. M. Shalet, A. Toogood, A. Rahim, and B. M. D. Brennan The Diagnosis of Growth Hormone Deficiency in Children and Adults Endocr. Rev., April 1, 1998; 19(2): 203 - 223. [Abstract] [Full Text]

				V. Tillmann, J. M. H. Buckler, M. S. Kibirige, D. A. Price, S. M. Shalet, J. K. H. Wales, M. G. Addison, M. S. Gill, A. J. Whatmore, and P. E. Clayton Biochemical Tests in the Diagnosis of Childhood Growth Hormone Deficiency J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 531 - 535. [Abstract] [Full Text] [PDF]

				F. I. Sharara and L. C. Giudice Role of Gorwth Hormone in Ovarian Physiology and Onest of Puberty Reproductive Sciences, January 1, 1997; 4(1): 2 - 7. [Abstract] [PDF]